Table 5.

Comparison of bleeding events, usage of hemostatic drugs or component blood transfusion between the COVID-19 cohort and the influenza cohort

	Total (n = 870)	COVID-19 (n = 461)	Influenza (n = 409)	p value
Bleeding events
Bronchus	25 (2.9%)	21 (4.6%)	4 (1.0%)	0.002
Gastrointestinal tract	24 (2.8%)	16 (3.5%)	8 (2.0%)	0.173
Mucocutaneous membrane	15 (1.7%)	11 (2.4%)	4 (1.0%)	0.125
Intracerebral hemorrhage	8 (0.9%)	7 (1.5%)	1 (0.2%)	0.073
Hemostatic drugs
Tranexamic acid	37 (4.3%)	25 (5.4%)	12 (2.9%)	0.069
Hemocoagulase	16 (1.8%)	11 (2.4%)	5 (1.2%)	0.219
Transfusion	21 (2.4%)	15 (3.3%)	6 (1.5%)	0.087